Thanks for the info. What's very interesting is that when I first bought Aurora at around .75 average the week ending 09/09, I spoke to Cam Battley who was then Aurora IR. I was working on a current model and a future projected revenue and earnings model based on the assumption that they would eventually able to sell all of the marijuana that their capacity would allow them to produce but needed some addt'l info such as anticipated net margins which he was unable to provide at the time. He was very knowledgeable and we spoke for probably 30-40 minutes. He told me a little about his time with Canopy prior to coming to Aurora and gave me quite a bit of good information about the industry in general and even noted that OGRMF and MTTQF were two other companies in the sector that he liked.
Note that at the time I spoke to him, it was already known that recreational use in Canada would likely be passed and it was also known that recreational use and medical use in additional US states was likely to pass as well. Aurora had already announced their planned expansion and new anticipated production capacity so basically since I spoke to him, nothing has changed. The most interesting thing I remember him specifically saying was that he felt that at the time of our conversation (again, when the US pink sheet version of Aurora was bouncing around in the .65-.75 range) that he thought it was fairly valued, and that when it had run to almost $1 a week or two prior that he thought it was OVERVALUED. Wonder what he thinks now that it's at $2.50-$3.00 with no change in fundamentals...
